CA9 and neoplasm: CAIX was expressed in 40% of patients, showing significant association with larger tumour size, higher staging and poorer disease-free survival (HR = 2.99 [1.78–5.02], p < 0.001), as well as overall survival (HR = 2.56 [1.41–4.65], p = 0.002).